Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • NPI Medicare & Medicaid
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.28
    OpenPayerBilling CodesDiseases and Disorders of the Circulatory SystemDRG 310-cardiac-arrhythmia-and-conduction-disorders-without-cc-mcc
    Ask Trek AI about this page

    Cardiac Arrhythmia and Conduction Disorders without CC/MCC: Inpatient Reimbursement Overview

    DRG 310 addresses inpatient admissions for cardiac arrhythmia and conduction disorders without Complication or Comorbidity or Major Complication or Comorbidity, covering uncomplicated rhythm disturbances and conduction abnormalities. This classification matters for inpatient reimbursement because it establishes the base Medicare payment and resource-use expectations for admissions without higher-severity secondary diagnoses.

    Customize your policy alerts

    Sign up for drg 310 policy alerts

    Get alerted when payer policies referencing 310 are released or updated.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    DRG 310 Overview

    DRG 310 covers inpatient admissions for cardiac arrhythmia and conduction disorders without Complication or Comorbidity or Major Complication or Comorbidity. Typical cases include symptomatic arrhythmias, conduction abnormalities, and related monitoring or stabilization that do not carry higher-severity secondary diagnoses. This grouping matters for Medicare payment because it sets the base inpatient reimbursement and resource expectations for uncomplicated rhythm and conduction management. Accurate coding and documentation determine assignment to this lower-severity Diagnosis-Related Group, which affects hospital revenue and length-of-stay benchmarks.

    Table of contents

    Progress1 / 3

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools

    Clinical Trials

    • Studies testing rapid in-hospital diagnostic and triage protocols for acute symptomatic arrhythmias, focusing on emergency department and early inpatient management pathways. These trials enroll patients admitted with symptomatic atrial fibrillation/flutter, supraventricular tachycardia, or bradyarrhythmias without major complications, comparing strategies such as expedited telemetry-based risk stratification, use of ambulatory monitoring initiation before discharge, or protocolized cardiology consultation. Results inform workflow, length-of-stay, and resource utilization decisions relevant to hospitals and payers by identifying safe ways to reduce unnecessary observation time while maintaining patient safety.
    • Comparative effectiveness trials evaluating rate- versus rhythm-control strategies and conservative versus invasive management in medically stable patients with new-onset or recurrent arrhythmias but no major comorbidities. These studies typically enroll general medicine and cardiology inpatients assigned to different antiarrhythmic strategies, noninvasive cardioversion timing, or early versus deferred electrophysiology referral, and measure outcomes such as recurrence, readmission, adverse events, and cost-effectiveness. Findings guide clinicians and payers on optimal inpatient treatment selection that balances clinical outcomes with medication and monitoring costs for this lower-acuity DRG.
    • Post-discharge outcomes and transitional-care research examining ambulatory monitoring, anticoagulation adherence, patient education, and remote follow-up to prevent readmissions and thromboembolic events in patients discharged after arrhythmia admission. These cohort studies or pragmatic trials enroll patients discharged without major complications to evaluate interventions like structured discharge pathways, wearable rhythm monitoring, or telehealth follow-up to detect recurrence and ensure guideline-concordant secondary prevention. This area is critical for payers and providers because reducing readmissions and downstream complications affects total cost of care and quality metrics for patients classified under this DRG.

    Related Codes

    209-COMPLEX-AORTIC-ARCH-PROCEDURES

    Complex Aortic Arch Procedures: Inpatient Reimbursement Overview

    212-CONCOMITANT-AORTIC-AND-MITRAL-VALVE-PROCEDURES

    Concomitant Aortic and Mitral Valve Procedures: Inpatient Reimbursement Overview

    213-ENDOVASCULAR-ABDOMINAL-AORTA-WITH-ILIAC-BRANCH-PROCEDURES

    Endovascular Abdominal Aorta with Iliac Branch Procedures: Inpatient Reimbursement Overview

    215-OTHER-HEART-ASSIST-SYSTEM-IMPLANT

    Other Heart Assist System Implant: Inpatient Reimbursement Overview

    216-CARDIAC-VALVE-AND-OTHER-MAJOR-CARDIOTHORACIC-PROCEDURES-WITH-CARDIAC-CATHETERIZATION-WITH-MCC

    Cardiac Valve and Other Major Cardiothoracic Procedures with Cardiac Catheterization with MCC: Inpatient Reimbursement Overview

    217-CARDIAC-VALVE-AND-OTHER-MAJOR-CARDIOTHORACIC-PROCEDURES-WITH-CARDIAC-CATHETERIZATION-WITH-CC

    Cardiac Valve and Other Major Cardiothoracic Procedures with Cardiac Catheterization with CC: Inpatient Reimbursement Overview

    218-CARDIAC-VALVE-AND-OTHER-MAJOR-CARDIOTHORACIC-PROCEDURES-WITH-CARDIAC-CATHETERIZATION-WITHOUT-CC-MCC

    Cardiac Valve and Other Major Cardiothoracic Procedures with Cardiac Catheterization without CC/MCC: Inpatient Reimbursement Overview

    219-CARDIAC-VALVE-AND-OTHER-MAJOR-CARDIOTHORACIC-PROCEDURES-WITHOUT-CARDIAC-CATHETERIZATION-WITH-MCC

    Cardiac Valve and Other Major Cardiothoracic Procedures with MCC: Inpatient Reimbursement Overview

    220-CARDIAC-VALVE-AND-OTHER-MAJOR-CARDIOTHORACIC-PROCEDURES-WITHOUT-CARDIAC-CATHETERIZATION-WITH-CC

    Cardiac Valve and Other Major Cardiothoracic Procedures without Cardiac Catheterization with CC: Inpatient Reimbursement Overview

    221-CARDIAC-VALVE-AND-OTHER-MAJOR-CARDIOTHORACIC-PROCEDURES-WITHOUT-CARDIAC-CATHETERIZATION-WITHOUT-CC-MCC

    Cardiac Valve and Other Major Cardiothoracic Procedures without Cardiac Catheterization without CC/MCC: Inpatient Reimbursement Overview

    Showing 1–10 of 100

    • More pages

    References

    1. 1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
    2. 2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
    3. 3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.
    Published by

    Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.